| 【Company Research】Chinasoft (354 HK) – FY1H22 beat, workforce restructuring in progress |
| 【Company Research】BOE Varitronix (710 HK) – Global auto display leader riding on smart cockpit trend |
| 【Company Research】Botanee Biotech (300957 CH) – 2Q in line; new brands in anti-aging and baby care to sustain growth |
| 【Fixed Income Research】Yanlord: Ability to navigate through deep downturn demonstrated once again |
| 【Company Research】Pinduoduo (PDD US) – Stronger recovery ahead |
| 【Company Research】PICC P&C (2328 HK) – Strong beat in 1H22 |
| 【Company Research】CPIC (2601 HK) – VNB growth turned positive in June |
| 【Company Research】UEG (467 HK) – On track volume growth along with good cost control |
| 【Company Research】Meituan (3690 HK) – More bullish on 2H22E recovery and profitability |
| 【Company Research】Tigermed (300347 CH) – Solid growth amid COVID-19 outbreaks |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
